| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Неврологический
> Рассеянный склероз | Регуляторное партнёрство
> Работа с регулирующими органами | 5 000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | Эндокринная
> Диабет и гипертония | Регуляторное партнёрство
> С другими защитниками здравоохранения | 10 000 | National | Sometimes | 119045009637 |
| We are one of three founding members of the South African Non-Communicable Disease Association. | Эндокринная
> Диабет и гипертония | Регуляторное партнёрство
> С другими защитниками здравоохранения | 10 000 | National | Sometimes | 119051187994 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Неврологический
> Рассеянный склероз | Влияние на политику и законодательство
> Влияние на политику и законодательство в сфере здравоохранения | 5 000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | Рак
> Рак: большинство видов | Влияние на политику и законодательство
> Влияние на политику и законодательство в сфере здравоохранения | 10 000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Рак
> Рак: большинство видов | Влияние на политику и законодательство
> Участвовать в публичных слушаниях и консультациях | 10 000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Неврологический
> Рассеянный склероз | Пропаганда доступного ценообразования
> Выступать за справедливое ценообразование на лекарства | 5 000 | Regional | Regularly | 119035905477 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | Ревматический
> Аксиальный спондилоартрит | Пропаганда доступного ценообразования
> Выступать за справедливое ценообразование на лекарства | Over 100,000 | National | Regularly | 119051166861 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Рак
> Рак: большинство видов | Пропаганда доступного ценообразования
> Участвовать в переговорах комиссии по пересмотру цен | 10 000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Рак
> Рак: большинство видов | Пропаганда доступного ценообразования
> Отстаивание включения продукта в списки возмещения/национальные формуляры | 10 000 | National | Regularly | 119044111428 |
| We often have to advocate for patients drug pricing, treatment baskets, and lists. | Ревматический
> Аксиальный спондилоартрит | Пропаганда доступного ценообразования
> Отстаивание включения продукта в списки возмещения/национальные формуляры | Over 100,000 | National | Regularly | 119051166861 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS [Multiple Sclerosis] treatments and by contributing the patient voice to policy, access, and reimbursement discussions. | Неврологический
> Рассеянный склероз | Улучшение путей доступа
> Обеспечение равного доступа к лекарствам/медицинской помощи | 5 000 | Regional | Regularly | 119035905477 |
| CANSA [Cancer Association of South Africa] engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. | Рак
> Рак: большинство видов | Улучшение путей доступа
> Обеспечение равного доступа к лекарствам/медицинской помощи | 10 000 | National | Regularly | 119044111428 |
| CANSA engages in policy advocacy, stakeholder consultations, and public submissions to promote equitable access to cancer prevention, diagnosis, and treatment. This includes contributing patient-centred perspectives on medicine access, reimbursement, and health system barriers through engagements with national health authorities, regulatory processes, and multi-stakeholder forums. Examples include: advocacy and submissions related to improving access to essential cancer medicines and diagnostics within the public health system; participation in consultative processes and policy discussions that inform regulatory and pricing frameworks impacting oncology treatments. | Рак
> Рак: большинство видов | Доказательный вклад пациента
> Используйте данные о пациентах для принятия решений | 10 000 | National | Regularly | 119044111428 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Неврологический
> Рассеянный склероз | Доказательный вклад пациента
> Предоставление реальных доказательств (RWE) регуляторным органам | 5 000 | Regional | Regularly | 119035905477 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. Our input is informed by lived experience, patient-reported challenges, and international collaboration through global MS networks, ensuring that patient needs, equity, and sustainability are considered in decision-making processes. | Неврологический
> Рассеянный склероз | Доказательный вклад пациента
> Используйте истории пациентов и нарративы на основе личного опыта | 5 000 | Regional | Regularly | 119035905477 |
| Have engaged the Department of Health. | Редкий
> Редкие заболевания: иммунные | Институциональное управление
> Обеспечить представительство в государственных консультативных органах | 100 | International | Rarely | 119036013383 |
| Multiple Sclerosis South Africa (MSSA) represents patient interests by advocating for access to affordable, effective MS treatments and by contributing the patient voice to policy, access, and reimbursement discussions. While MSSA does not set or negotiate drug prices, we engage with regulators, policymakers, and advisory bodies to highlight the real-world impact of pricing and access decisions on people living with MS, particularly in a South African and broader African context. | Неврологический
> Рассеянный склероз | Институциональное управление
> Эффективная работа в многосторонних сетях заинтересованных сторон | 5 000 | Regional | Regularly | 119035905477 |
| We are founder members of the SA [South Africa] NCD [Non-Communicable Disease] Alliance. | Эндокринная
> Диабет и гипертония | Институциональное управление
> Поддерживать официальный статус организации, действующей в общественных интересах или являющейся благотворительной | 10 000 | National | Sometimes | 119045009637 |
взаимодействия
действия и защита интересов
3 упоминания
